Fairmount Healthcare Fund II L.P. (CIK 0001769651)

Latest company ownership

Shares held
3,914,458
Last filed at
Oct 27, 2025
Confidence Score
87.5
2025Q4
Confidence Score History
2021Q3 2025Q4
Shares held
2,209,025
Last filed at
Oct 9, 2025
Confidence Score
87.5
2025Q4
Confidence Score History
2024Q3 2025Q4
Shares held
1,387,866
Last filed at
Jun 23, 2025
Confidence Score
87.5
2025Q4
Confidence Score History
2025Q4 2025Q4
Shares held
51,166
Last filed at
Jan 31, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2023Q3 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Dec 4, 2025 Dec 8, 2025 CRESCENT BIOPHARMA, INC. Director Buy 100.0 +1,360,000 97.99% ✗ $18.2M
Oct 23, 2025 Oct 27, 2025 Viridian Therapeutics, Inc.\DE Director Buy 100.0 +454,545 13.14% ✗ $10M
Oct 7, 2025 Oct 9, 2025 Zenas BioPharma, Inc. Director Buy 100.0 +316,219 16.71% ✗ $6M
Sep 13, 2024 Sep 17, 2024 Viridian Therapeutics, Inc.\DE Director Buy 100.0 +1,600,000 86.68% ✗ $30M
Sep 16, 2024 Sep 17, 2024 Zenas BioPharma, Inc. Director Buy 100.0 +300,000 18.83% ✗ $5.1M
Sep 16, 2024 Sep 16, 2024 Zenas BioPharma, Inc. Director Buy 100.0 +300,000 22.99% ✗ $5.1M
Jan 22, 2024 Jan 24, 2024 Viridian Therapeutics, Inc.\DE Director Buy 100.0 +476,190 34.77% ✗ $10M
Jul 13, 2023 Jul 17, 2023 Apogee Therapeutics, Inc. Director Buy 100.0 +2,941,176 100.00% ✗ $50M
Aug 17, 2022 Aug 19, 2022 Viridian Therapeutics, Inc.\DE Director Buy 100.0 +425,531 45.07% ✗ $10M
Sep 21, 2021 Sep 23, 2021 Viridian Therapeutics, Inc.\DE Director Buy 100.0 +909,000 2590.33% ✗ $10M